Renal Cancer
Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far From the Tree
September 20, 2017
Management of Atypical Renal Cell Carcinomas
September 19, 2017
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma
September 19, 2017
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
September 18, 2017
Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system
September 18, 2017
Advances on immunotherapy in genitourinary and renal cell carcinoma
September 18, 2017
A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma: Expert Commentary
September 15, 2017
A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma
September 15, 2017
Predictors of Long-term Survival after Renal Cancer Surgery
September 15, 2017
Differences in Urinary Renal Failure Biomarkers in Cancer Patients Initially Treated with Cisplatin
September 14, 2017
Evaluation of Factors Affecting Metastasis for Renal Cell Carcinoma Based on Current Guidelines in Japan
September 14, 2017
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma
September 14, 2017
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
September 13, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
September 13, 2017
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies
September 12, 2017
Surgical management of metastatic renal cell carcinoma
September 12, 2017
Second-line systemic therapy in metastatic renal-cell carcinoma: A review
September 11, 2017